Bivision Biomedical Technology (Nanjing) Co., Ltd. specializes in advanced biomedical technologies focused on the development of innovative diagnostic and therapeutic solutions. The company emphasizes its commitment to research and development, leveraging cutting-edge techniques in molecular biology and biochemistry to create products that enhance disease detection and treatment. Their pipeline includes a range of diagnostic kits and therapeutic agents designed to address various health conditions, showcasing their dedication to improving patient outcomes through scientific innovation.

The technologies employed by Bivision encompass a variety of methodologies, including but not limited to, high-throughput screening, biomarker discovery, and personalized medicine approaches. The company utilizes state-of-the-art laboratory techniques to ensure the accuracy and reliability of their products, which are aimed at both clinical and research applications. By integrating scientific expertise with technological advancements, Bivision Biomedical Technology aims to contribute significantly to the field of biomedicine, ultimately striving to meet the evolving needs of healthcare professionals and patients alike.

China

Bivision is a China-based biopharmaceutical company that develops visually targeted radionuclide therapies for the treatment of cancer across the globe.

Bivision Biomedical Technology (Nanjing) Co., Ltd.

Company Details